These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 30918805)
1. Functional and anatomical evaluation of the effect of nepafenac in prevention of macular edema after phacoemulsification in diabetic patients. Mokbel T; Saleh S; Abdelkader M; El-Khouly SE; Abou Samra W; Mamdouh M Int J Ophthalmol; 2019; 12(3):387-392. PubMed ID: 30918805 [TBL] [Abstract][Full Text] [Related]
2. Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema. Şahin AK; Kükner AŞ; Ulaş F; Doğan Ü Int J Ophthalmol; 2020; 13(12):1901-1907. PubMed ID: 33344188 [TBL] [Abstract][Full Text] [Related]
3. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema. Mathys KC; Cohen KL Eye (Lond); 2010 Jan; 24(1):90-6. PubMed ID: 19229275 [TBL] [Abstract][Full Text] [Related]
4. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification. Tzelikis PF; Morato CS; Neves NT; Hida WT; Alves MR J Cataract Refract Surg; 2018 Apr; 44(4):440-446. PubMed ID: 29685777 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of the efficacy and safety of bromfenac, nepafenac and diclofenac sodium for the prevention of cystoid macular edema after phacoemulsification. Chinchurreta Capote AM; Lorenzo Soto M; Rivas Ruiz F; Caso Peláez E; García Vazquez A; ; Ramos Suárez A Int J Ophthalmol; 2018; 11(7):1210-1216. PubMed ID: 30046541 [TBL] [Abstract][Full Text] [Related]
6. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac. Wolf EJ; Braunstein A; Shih C; Braunstein RE J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac. Cervantes-Coste G; Sánchez-Castro YG; Orozco-Carroll M; Mendoza-Schuster E; Velasco-Barona C Clin Ophthalmol; 2009; 3():219-26. PubMed ID: 19668569 [TBL] [Abstract][Full Text] [Related]
8. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Miyake K; Ota I; Miyake G; Numaga J J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758 [TBL] [Abstract][Full Text] [Related]
9. Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification. Milla E; Stirbu O; Franco IJ; Hernández SJG; Rios J; Duch S Int Ophthalmol; 2017 Oct; 37(5):1147-1153. PubMed ID: 27771823 [TBL] [Abstract][Full Text] [Related]
10. Comparison of macular thickness by optical coherence tomography measurements after uneventful phacoemulsification using ketorolac tromethamine, nepafenac, vs a control group, preoperatively and postoperatively. Stock RA; Galvan DK; Godoy R; Bonamigo EL Clin Ophthalmol; 2018; 12():607-611. PubMed ID: 29636596 [TBL] [Abstract][Full Text] [Related]
11. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study. Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of optical coherence tomography-diagnosed postoperative cystoid macular oedema in patients following uncomplicated phaco-emulsification cataract surgery. Vukicevic M; Gin T; Al-Qureshi S Clin Exp Ophthalmol; 2012 Apr; 40(3):282-7. PubMed ID: 21718410 [TBL] [Abstract][Full Text] [Related]
13. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo. McCafferty S; Harris A; Kew C; Kassm T; Lane L; Levine J; Raven M BMC Ophthalmol; 2017 Feb; 17(1):16. PubMed ID: 28219426 [TBL] [Abstract][Full Text] [Related]
14. Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy. Sarfraz MH; Haq RI; Mehboob MA Pak J Med Sci; 2017; 33(1):210-214. PubMed ID: 28367202 [TBL] [Abstract][Full Text] [Related]
15. Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients. Alnagdy AA; Abouelkheir HY; El-Khouly SE; Tarshouby SM Int J Ophthalmol; 2018; 11(4):616-622. PubMed ID: 29675380 [TBL] [Abstract][Full Text] [Related]
16. Multifocal electroretinogram in diabetic subjects. Abdelkader M Saudi J Ophthalmol; 2013 Apr; 27(2):87-96. PubMed ID: 24227968 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy. Singh R; Alpern L; Jaffe GJ; Lehmann RP; Lim J; Reiser HJ; Sall K; Walters T; Sager D Clin Ophthalmol; 2012; 6():1259-69. PubMed ID: 22927737 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976 [TBL] [Abstract][Full Text] [Related]
19. [Macular edema after an uncomplicated cataract surgery]. Jurecka T; Bátková Z; Ventruba J Cesk Slov Oftalmol; 2007 Jul; 63(4):262-73. PubMed ID: 17682606 [TBL] [Abstract][Full Text] [Related]
20. Topical nepafenac in the treatment of diabetic macular edema. Callanan D; Williams P Clin Ophthalmol; 2008 Dec; 2(4):689-92. PubMed ID: 19668417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]